KRYS
Krystal Biotech, Inc.
NASDAQ · Healthcare · Biotechnology · US
$320.25
+1.16%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.31x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.04x
- Net debt / EBITDA
- -1.90x
Liquidity & coverage
- Current ratio
- 8.32x
- Quick ratio
- 7.96x
- Cash ratio
- 6.64x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $932.3M
Cash & dividend
- FCF / debt
- 29.12x
- Cash flow / debt
- 30.76x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026